Oxford Biomedica (OXB) RNS Announcements

Add to Alert list
Date Time Source Announcement
17 Aug 1999 07:30 AM
RNS
Interim Results
26 Jul 1999 09:17 AM
RNS
Directorate

Oxford Biomedica is a company that specialises in cell and gene therapy, and is a leader in the development of gene-based medicines. They work with pharmaceutical and biotechnology companies to develop and manufacture viral vectors, including lentivirus, adeno-associated virus, and adenoviral vectors.

Headquartered in Oxford, Oxford Biomedica has manufacturing facilities in Oxfordshire, UK, Lyon and Strasbourg, France, and near Boston, MA, US.

Oxford Biomedica share price listed in London under the ticker OXB at 2,570p.

UK 100